Biomedical Engineering Toronto Metropolitan University

Overview

The Biomedical Engineering programme at Toronto Metropolitan University provides a collaborative environment for students to advance their research and engage with industry-related projects. This curriculum is designed to meet the growing global demand for sophisticated medical equipment and improved clinical procedures. Students benefit from a professional network of experienced faculty supervisors and leading research facilities.

Why Biomedical Engineering at Toronto Metropolitan University?

Toronto Metropolitan University offers a unique ecosystem for innovation through its dedicated Biomedical Zone, which encourages experiential learning and cross-sector collaboration. Students have access to the Institute for Biomedical Engineering, Science and Technology (iBEST), a premier partnership with St. Michael’s Hospital. The university also provides specialised laboratories for microfluidics, tissue engineering, and biomedical signal analyses, ensuring students work with world-class resources in the heart of Toronto.

Tuition Fee Breakdown

• International fee: CAD 30174 per year
• National fee: CAD 9665 per year

Visit the Fees and Funding section for a breakdown in your local currency.

Syllabus

Modules may include:

• Anatomy and Physiology
• Foundations in Biomedical Engineering
• Advanced Imaging
• Advances in Biomaterials
• Advances in Tissue Engineering
• Biomedical Ultrasound
• Genetic Engineering
• Design of BioMEMS
• Modelling of Biomedical Systems

Careers with Biomedical Engineering

Graduates are prepared for high-impact roles within the healthcare industry, particularly in research and development. The programme equips students with the technical expertise required to design better medical devices and sophisticated diagnostic tools. Career paths typically include positions in biomedical R&D, which is currently recognised as a leading sector for professional growth in health technology. Graduates often find opportunities within research hospitals, such as the University Health Network, or within private medical technology companies focusing on nanobiotechnology and biomechanics.